​

Funding Round

Series A - Lysosomal Therapeutics

Series A - Lysosomal Therapeutics

Investment Firm

Overview

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

Announced Date

Feb 03, 2015

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorPartners Innovation Fund
Participant InvestorSanofi Ventures
Participant InvestorHatteras Venture Partners
Participant InvestorRoche Venture Fund
Participant InvestorAtlas Venture

Round Details and Background

Lysosomal Therapeutics raised $20000000 on 2015-02-03 in Series A

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 03, 2015
Series A - Lysosomal Therapeutics
8-20.0M
May 12, 2014
Seed Round - Lysosomal Therapeutics
7-4.8M

Recent Activity

There is no recent news or activity for this profile.